Many people looking into skin serums come across copper tripeptide-1, also known as GHK-Cu, and want to know what the label actually claims and what research backs it up. Here is a plain-language look at what the compound is, what it is marketed for, and what the evidence shows so far.
Key takeaways
- Copper tripeptide-1 is marketed as a cosmetic ingredient, sold under the brand name YVTYVT Copper Peptides Facial Serum.
- The label describes it as a methylating agent used topically for skin appearance.
- Labeled use claims include repairing and tightening skin and reducing signs of premature aging.
- One registered clinical trial in the sample data is studying a related topical formulation (GHK-Cu gel) for acute wound healing.
- No adverse event reports were available in the data reviewed.
What Copper Tripeptide-1 Is
Copper tripeptide-1 is a small copper-binding peptide, chemically identified by PubChem CID 71587328. Its label classifies it under the pharmacologic class "Methylating Agent." No detailed mechanism of action was provided in the label data reviewed.
What Copper Tripeptide-1 Is Approved For
The labeled indications describe copper tripeptide-1 as a topical product intended to repair, tighten, and combat signs of premature aging, while helping restore skin's natural density and firmness. The label instructs twice-daily use and notes that consistent use supports the best results. It is sold under the brand name YVTYVT Copper Peptides Facial Serum. No boxed warning is present on this label.
What the Evidence Shows
The available data lists one registered clinical trial connected to this compound family. That trial, a Phase 2 study titled "Topical GHK-Cu Gel for Acute Skin Wound Healing," is currently recruiting participants to evaluate a topical GHK-Cu gel for wound healing outcomes.
Reported Side Effects
No adverse event reports were available in the data reviewed for copper tripeptide-1, so no side effect pattern can be summarized at this time.